AI
Saturday, July 07, 2018 11:00:46 AM
To be honest, I am almost all-in right now aside from some preferred shares and warrants in other tickers.
Actimab data should come this month and may just be the spark that ignites widespread recognition of the raging-fire potential of the AWE technology platform (as a revolution in modern medicine). News next week would certainly align well with the chart technicals!
If this explodes to $10/share on good study data, I will not be surprised in the slightest.
The risk of bad data being reported seems exceedingly small from my perspective - especially since the company quietly added Actimab-B, -C, and -P to their pipeline - making this a perfect risk:reward scenario.
OMID
Recent ATNM News
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
